We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Dual-loss of PBRM1 and RAD51 identifies hyper-sensitive subset patients to immunotherapy in clear cell renal cell carcinoma

    Background

    Homologous recombination deficiency (HRD), though largely uncharacterized in clear cell renal cell carcinoma (ccRCC), was found associated...

    Ziyang Xu, Wenbin Jiang, ... Jiejie Xu in Cancer Immunology, Immunotherapy
    Article Open access 12 April 2024
  2. In-vitro model to mimic T cell subset change in human PDAC organoid co-culture

    Purpose

    Immunotherapies have largely failed as treatment options for pancreatic ductal adenocarcinoma (PDAC). In this field, clinical translational...

    M. Knoblauch, T. Ma, ... Bernhard W. Renz in Journal of Cancer Research and Clinical Oncology
    Article Open access 20 July 2023
  3. A CAR-T response prediction model for r/r B-NHL patients based on a T cell subset nomogram

    Background

    Chimeric antigen receptor (CAR) T cells for refractory or relapsed (r/r) B cell no-Hodgkin lymphoma (NHL) patients have shown promising...

    **aomei Zhang, Rui Sun, ... Mingfeng Zhao in Cancer Immunology, Immunotherapy
    Article Open access 27 January 2024
  4. miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease

    Complete elimination of B-cell acute lymphoblastic leukemia (B-ALL) by a risk-adapted primary treatment approach remains a clinical key objective,...

    Carolina Caserta, Silvia Nucera, ... Bernhard Gentner in Leukemia
    Article 28 August 2023
  5. PD-1 signaling uncovers a pathogenic subset of T cells in inflammatory arthritis

    Background

    PD-1 is an immune checkpoint on T cells, and interventions to block this receptor result in T cell activation and enhanced immune response...

    Johanna Straube, Shoiab Bukhari, ... Adam Mor in Arthritis Research & Therapy
    Article Open access 22 January 2024
  6. Long-term lymphocyte subset number reconstitution is unique but comparable between umbilical cord blood and unrelated bone marrow transplantation

    The number of umbilical cord blood transplantation (U-CBT) procedures has been growing annually, but little research has been done on long-term...

    Keiko Tsumita, Shinsuke Takagi, ... Yukako Koike in International Journal of Hematology
    Article 26 February 2024
  7. A Subset of Salivary Intercalated Duct Lesions Harbors Recurrent CTNNB1 and HRAS Mutations: A Molecular Link to Basal Cell Adenoma and Epithelial-Myoepithelial Carcinoma?

    Background

    Intercalated duct lesions (IDLs) are benign salivary gland proliferations that resemble normal intercalated ducts and are subdivided into...

    Anne C. McLean, Lisa M. Rooper, ... Justin A. Bishop in Head and Neck Pathology
    Article 08 December 2022
  8. Photodynamic Therapy in Treating a Subset of Basal Cell Carcinoma: Strengths, Shortcomings, Comparisons with Surgical Modalities, and Potential Role as Adjunctive Therapy

    Basal cell carcinoma (BCC) is the most common skin cancer, for which there are multiple treatment options, including the gold standard Mohs...

    Maggie Chen, Albert Zhou, Amor Khachemoune in American Journal of Clinical Dermatology
    Article 02 December 2023
  9. Enrichment of a subset of Neanderthal polymorphisms in autistic probands and siblings

    Homo sapiens and Neanderthals underwent hybridization during the Middle/Upper Paleolithic age, culminating in retention of small amounts of...

    Rini Pauly, Layla Johnson, ... Emily L. Casanova in Molecular Psychiatry
    Article Open access 17 May 2024
  10. LASS2 enhances chemosensitivity to cisplatin by inhibiting PP2A-mediated β-catenin dephosphorylation in a subset of stem-like bladder cancer cells

    Background

    The benefits of first-line, cisplatin-based chemotherapy for muscle-invasive bladder cancer are limited due to intrinsic or acquired...

    Hong** Shi, Zhiyong Tan, ... Haifeng Wang in BMC Medicine
    Article Open access 09 January 2024
  11. Shank2 identifies a subset of glycinergic neurons involved in altered nociception in an autism model

    Background

    Autism Spectrum Disorders (ASD) patients experience disturbed nociception in the form of either hyposensitivity to pain or allodynia. A...

    Florian Olde Heuvel, Najwa Ouali Alami, ... Francesco Roselli in Molecular Autism
    Article Open access 14 June 2023
  12. Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLL

    Cancer pathogenesis involves the interplay of tumor- and microenvironment-derived stimuli. Here we focused on the influence of an immunomodulatory...

    Gerardo Ferrer, Byeongho Jung, ... Nicholas Chiorazzi in Leukemia
    Article Open access 02 May 2021
  13. CD34+THY1+ synovial fibroblast subset in arthritic joints has high osteoblastic and chondrogenic potentials in vitro

    Objective

    Synovial fibroblasts (SFs) in rheumatoid arthritis (RA) and osteoarthritis (OA) play biphasic roles in joint destruction and regeneration of...

    Seiji Noda, Tadashi Hosoya, ... Shinsuke Yasuda in Arthritis Research & Therapy
    Article Open access 15 February 2022
  14. Novel NONO::TFE3 fusion and ALK co-expression identified in a subset of cutaneous microcystic/reticular schwannoma

    Microcystic/reticular schwannoma (MRS) is a benign variant of schwannoma with a predilection for the gastrointestinal tract and skin. To date,...

    Karen J. Fritchie, Josephine K. Dermawan, ... Steven D. Billings in Virchows Archiv
    Article 19 July 2023
  15. Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses

    Allogeneic stem cell transplantation (alloSCT), following induction chemotherapy, can be curative for hemato-oncology patients due to powerful...

    Jesper van Eck van der Sluijs, Diede van Ens, ... Willemijn Hobo in Cancer Immunology, Immunotherapy
    Article Open access 01 April 2021
  16. NSCLC patients with a changing T grade after operation may represent a special subset of tumor staging

    Background

    There is consensus that postoperative adjuvant therapy is not recommended in patients with stage 1a non-small cell lung cancer (NSCLC)....

    Kun-Peng Feng, Kai Fu, ... Chang Li in Journal of Cancer Research and Clinical Oncology
    Article 31 May 2023
  17. POU2F3-expressing intraepithelial small-cell carcinoma with mixed small-cell carcinoma and conventional-type urothelial carcinoma of the urinary bladder

    Based on lineage-specific transcription factors, small-cell neuroendocrine carcinoma (SmCC) of the urinary bladder has recently been subtyped into...

    Laurence A. Galea, Ahida Batrouney, ... Michael Christie in Virchows Archiv
    Article 11 April 2024
  18. KRAS codon 12 mutations characterize a subset of de novo proliferating “metaplastic” Warthin tumors

    Warthin tumor (WT; synonym: cystadenolymphoma) represents one of the most frequent salivary gland tumors with a frequency equaling or even...

    Abbas Agaimy, Konstantinos Mantsopoulos, ... Robert Stoehr in Virchows Archiv
    Article Open access 08 February 2023
Did you find what you were looking for? Share feedback.